May 7, 2026

Glooko Wins “Best Overall MedTech Software” in 2026 MedTech Breakthrough Awards

Glooko is the winner of the 2026 MedTech Breakthrough ‘Best Overall MedTech Software’ award for its diabetes and glycemic management software portfolio.

Read More

May 4, 2026

Mark Clements of Glooko recognized on Becker’s Healthcare’s 2026 ‘Great leaders in healthcare’ list

Glooko announced that Chief Medical and Strategy Officer Mark Clements, M.D., Ph.D., was named one of Becker's Healthcare's 2026 'Great leaders in healthcare.'

Read More

April 23, 2026

New EndoTool IV data presented at AACE show virtual elimination of severe hypoglycemia across 19 hospitals

Glooko revealed new data at AACE 2026 that demonstrated virtual elimination of severe hypoglycemia across 19 hospitals using EndoTool IV.

Read More

March 10, 2026

Glooko to Expand EMEA CGM Connectivity with Roche Accu-Chek® SmartGuide Integration

The Glooko diabetes management platform will integrate with the Roche Accu-Chek SmartGuide CGM solution across select European countries.

Read More

February 3, 2026

Glooko Appoints Former UCSF Health CEO and National Healthcare Leader Mark Laret to Board of Directors

Glooko announced the appointment of Mark Laret, one of the nation’s leading healthcare operators, innovators, and strategists, to its Board of Directors.

Read More

September 23, 2025

Glooko Announces Acquisition of Monarch Medical Technologies, Maker of EndoTool® Glucose Management System, to Expand Connected Diabetes Care Offerings

Glooko acquired Monarch Medical Technologies, developer of the EndoTool Glucose Management System, to expand into inpatient glycemic management.

Read More